{
  "labels": [
    "1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING",
    "1.2 PSYCHOLOGICAL AND SOCIOECONOMIC PROCESSES",
    "1.3 CHEMICAL AND PHYSICAL SCIENCES",
    "1.4 METHODOLOGIES AND MEASUREMENTS",
    "1.5 RESOURCES AND INFRASTRUCTURE (UNDERPINNING)",
    "2.1 BIOLOGICAL AND ENDOGENOUS FACTORS",
    "2.2 FACTORS RELATING TO PHYSICAL ENVIRONMENT",
    "2.3 PSYCHOLOGICAL, SOCIAL AND ECONOMIC FACTORS",
    "2.4 SURVEILLANCE AND DISTRIBUTION",
    "2.5 RESEARCH DESIGN AND METHODOLOGIES (AETIOLOGY)",
    "2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY)",
    "3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELL-BEING",
    "3.2 INTERVENTIONS TO ALTER PHYSICAL AND BIOLOGICAL ENVIRONMENTAL RISKS",
    "3.3 NUTRITION AND CHEMOPREVENTION",
    "3.4 VACCINES",
    "3.5 RESOURCES AND INFRASTRUCTURE (PREVENTION)",
    "4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES",
    "4.2 EVALUATION OF MARKERS AND TECHNOLOGIES",
    "4.3 INFLUENCES AND IMPACT",
    "4.4 POPULATION SCREENING",
    "4.5 RESOURCES AND INFRASTRUCTURE (DETECTION)",
    "5.1 PHARMACEUTICALS",
    "5.2 CELLULAR AND GENE THERAPIES",
    "5.3 MEDICAL DEVICES",
    "5.4 SURGERY",
    "5.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES",
    "5.6 PSYCHOLOGICAL AND BEHAVIOURAL",
    "5.7 PHYSICAL",
    "5.8 COMPLEMENTARY",
    "5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT)",
    "6.1 PHARMACEUTICALS",
    "6.2 CELLULAR AND GENE THERAPIES",
    "6.3 MEDICAL DEVICES",
    "6.4 SURGERY",
    "6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES",
    "6.6 PSYCHOLOGICAL AND BEHAVIOURAL",
    "6.7 PHYSICAL",
    "6.8 COMPLEMENTARY",
    "6.9 RESOURCES AND INFRASTRUCTURE (TREATMENT EVALUATION)",
    "7.1 INDIVIDUAL CARE NEEDS",
    "7.2 END OF LIFE CARE",
    "7.3 MANAGEMENT AND DECISION MAKING",
    "7.4 RESOURCES AND INFRASTRUCTURE (DISEASE MANAGEMENT)",
    "8.1 ORGANISATION AND DELIVERY OF SERVICES",
    "8.2 HEALTH AND WELFARE ECONOMICS",
    "8.3 POLICY, ETHICS AND RESEARCH GOVERNANCE",
    "8.4 RESEARCH DESIGN AND METHODOLOGIES (HEALTH SERVICES)",
    "8.5 RESOURCES AND INFRASTRUCTURE (HEALTH SERVICES)"
  ],
  "label2id": {
    "1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING": 0,
    "1.2 PSYCHOLOGICAL AND SOCIOECONOMIC PROCESSES": 1,
    "1.3 CHEMICAL AND PHYSICAL SCIENCES": 2,
    "1.4 METHODOLOGIES AND MEASUREMENTS": 3,
    "1.5 RESOURCES AND INFRASTRUCTURE (UNDERPINNING)": 4,
    "2.1 BIOLOGICAL AND ENDOGENOUS FACTORS": 5,
    "2.2 FACTORS RELATING TO PHYSICAL ENVIRONMENT": 6,
    "2.3 PSYCHOLOGICAL, SOCIAL AND ECONOMIC FACTORS": 7,
    "2.4 SURVEILLANCE AND DISTRIBUTION": 8,
    "2.5 RESEARCH DESIGN AND METHODOLOGIES (AETIOLOGY)": 9,
    "2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY)": 10,
    "3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELL-BEING": 11,
    "3.2 INTERVENTIONS TO ALTER PHYSICAL AND BIOLOGICAL ENVIRONMENTAL RISKS": 12,
    "3.3 NUTRITION AND CHEMOPREVENTION": 13,
    "3.4 VACCINES": 14,
    "3.5 RESOURCES AND INFRASTRUCTURE (PREVENTION)": 15,
    "4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES": 16,
    "4.2 EVALUATION OF MARKERS AND TECHNOLOGIES": 17,
    "4.3 INFLUENCES AND IMPACT": 18,
    "4.4 POPULATION SCREENING": 19,
    "4.5 RESOURCES AND INFRASTRUCTURE (DETECTION)": 20,
    "5.1 PHARMACEUTICALS": 21,
    "5.2 CELLULAR AND GENE THERAPIES": 22,
    "5.3 MEDICAL DEVICES": 23,
    "5.4 SURGERY": 24,
    "5.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES": 25,
    "5.6 PSYCHOLOGICAL AND BEHAVIOURAL": 26,
    "5.7 PHYSICAL": 27,
    "5.8 COMPLEMENTARY": 28,
    "5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT)": 29,
    "6.1 PHARMACEUTICALS": 30,
    "6.2 CELLULAR AND GENE THERAPIES": 31,
    "6.3 MEDICAL DEVICES": 32,
    "6.4 SURGERY": 33,
    "6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES": 34,
    "6.6 PSYCHOLOGICAL AND BEHAVIOURAL": 35,
    "6.7 PHYSICAL": 36,
    "6.8 COMPLEMENTARY": 37,
    "6.9 RESOURCES AND INFRASTRUCTURE (TREATMENT EVALUATION)": 38,
    "7.1 INDIVIDUAL CARE NEEDS": 39,
    "7.2 END OF LIFE CARE": 40,
    "7.3 MANAGEMENT AND DECISION MAKING": 41,
    "7.4 RESOURCES AND INFRASTRUCTURE (DISEASE MANAGEMENT)": 42,
    "8.1 ORGANISATION AND DELIVERY OF SERVICES": 43,
    "8.2 HEALTH AND WELFARE ECONOMICS": 44,
    "8.3 POLICY, ETHICS AND RESEARCH GOVERNANCE": 45,
    "8.4 RESEARCH DESIGN AND METHODOLOGIES (HEALTH SERVICES)": 46,
    "8.5 RESOURCES AND INFRASTRUCTURE (HEALTH SERVICES)": 47
  },
  "id2label": {
    "0": "1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING",
    "1": "1.2 PSYCHOLOGICAL AND SOCIOECONOMIC PROCESSES",
    "2": "1.3 CHEMICAL AND PHYSICAL SCIENCES",
    "3": "1.4 METHODOLOGIES AND MEASUREMENTS",
    "4": "1.5 RESOURCES AND INFRASTRUCTURE (UNDERPINNING)",
    "5": "2.1 BIOLOGICAL AND ENDOGENOUS FACTORS",
    "6": "2.2 FACTORS RELATING TO PHYSICAL ENVIRONMENT",
    "7": "2.3 PSYCHOLOGICAL, SOCIAL AND ECONOMIC FACTORS",
    "8": "2.4 SURVEILLANCE AND DISTRIBUTION",
    "9": "2.5 RESEARCH DESIGN AND METHODOLOGIES (AETIOLOGY)",
    "10": "2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY)",
    "11": "3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELL-BEING",
    "12": "3.2 INTERVENTIONS TO ALTER PHYSICAL AND BIOLOGICAL ENVIRONMENTAL RISKS",
    "13": "3.3 NUTRITION AND CHEMOPREVENTION",
    "14": "3.4 VACCINES",
    "15": "3.5 RESOURCES AND INFRASTRUCTURE (PREVENTION)",
    "16": "4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES",
    "17": "4.2 EVALUATION OF MARKERS AND TECHNOLOGIES",
    "18": "4.3 INFLUENCES AND IMPACT",
    "19": "4.4 POPULATION SCREENING",
    "20": "4.5 RESOURCES AND INFRASTRUCTURE (DETECTION)",
    "21": "5.1 PHARMACEUTICALS",
    "22": "5.2 CELLULAR AND GENE THERAPIES",
    "23": "5.3 MEDICAL DEVICES",
    "24": "5.4 SURGERY",
    "25": "5.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES",
    "26": "5.6 PSYCHOLOGICAL AND BEHAVIOURAL",
    "27": "5.7 PHYSICAL",
    "28": "5.8 COMPLEMENTARY",
    "29": "5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT)",
    "30": "6.1 PHARMACEUTICALS",
    "31": "6.2 CELLULAR AND GENE THERAPIES",
    "32": "6.3 MEDICAL DEVICES",
    "33": "6.4 SURGERY",
    "34": "6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES",
    "35": "6.6 PSYCHOLOGICAL AND BEHAVIOURAL",
    "36": "6.7 PHYSICAL",
    "37": "6.8 COMPLEMENTARY",
    "38": "6.9 RESOURCES AND INFRASTRUCTURE (TREATMENT EVALUATION)",
    "39": "7.1 INDIVIDUAL CARE NEEDS",
    "40": "7.2 END OF LIFE CARE",
    "41": "7.3 MANAGEMENT AND DECISION MAKING",
    "42": "7.4 RESOURCES AND INFRASTRUCTURE (DISEASE MANAGEMENT)",
    "43": "8.1 ORGANISATION AND DELIVERY OF SERVICES",
    "44": "8.2 HEALTH AND WELFARE ECONOMICS",
    "45": "8.3 POLICY, ETHICS AND RESEARCH GOVERNANCE",
    "46": "8.4 RESEARCH DESIGN AND METHODOLOGIES (HEALTH SERVICES)",
    "47": "8.5 RESOURCES AND INFRASTRUCTURE (HEALTH SERVICES)"
  },
  "optimal_thresholds": [
    0.45000000000000007,
    0.50000000000000013,
    0.1,
    0.30000000000000004,
    0.3500000000000001,
    0.7500000000000002,
    0.4500000000000001,
    0.25000000000000006,
    0.8000000000000002,
    0.40000000000000013,
    0.15000000000000002,
    0.9000000000000002,
    0.20000000000000004,
    0.25000000000000006,
    0.9000000000000002,
    0.40000000000000013,
    0.50000000000000013,
    0.7500000000000002,
    0.25000000000000006,
    0.8500000000000002,
    0.9000000000000002,
    0.30000000000000004,
    0.3500000000000001,
    0.7500000000000002,
    0.20000000000000004,
    0.5500000000000002,
    0.3500000000000001,
    0.1,
    0.5,
    0.1,
    0.8000000000000002,
    0.45000000000000007,
    0.7000000000000002,
    0.3500000000000001,
    0.8000000000000002,
    0.8000000000000002,
    0.6500000000000001,
    0.9000000000000002,
    0.25000000000000006,
    0.25000000000000006,
    0.5500000000000002,
    0.6000000000000002,
    0.25000000000000006,
    0.8000000000000002,
    0.3500000000000001,
    0.4000000000000006,
    0.45000000000000007,
    0.6500000000000001
  ],
  "base_model_name": "grants_biomedbert",
  "max_len": 512
}